Krupp L., Banwell B., Tenembaum S., for the International Pediatric MS Study Group.Consensus definitions proposed for pediatric multiple sclerosis. Neurology2007; 68: S7—12.
2.
Ness JM, Chabas D., Sadovnick AD, Pohl D., Banwell B., Weinstock-Guttman B.Clinical features of children and adolescents with multiple sclerosis. Neurology2007; 68(16 Suppl 2): S37—45.
3.
Pohl D., Waubant E., Banwell B., Chabas D., Chitnis T., Weinstock-Guttman B. et al. Treatment of pediatric multiple sclerosis and variants. Neurology2007; 68 (16 Suppl 2): S54—65.
4.
Pugliatti M. , Riise T., Sotgiu MA, Satta WM, Sotgiu S., Pirastru MI et al. Evidence of early childhood as the susceptibility period in multiple sclerosis: space-time cluster analysis in a Sardinian population. Am J Epidemiol2006 ; 164(4): 326—33.
5.
Krone B., Pohl D., Rostasy K., Kahler E., Brunner E., Oeffner F. et al. Common infectious agents in mutiple sclerosis: a case-control study in children. Multiple sclerosis2007 ; 14: 136—9.
6.
Pohl D., Krone B., Rostasy K., Kahler E., Brunner E., Lehnert M. et al. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology2006; 67(11): 2063—5.
7.
Alotaibi S., Kennedy J., Tellier R., Stephens D., Banwell B.Epstein—Barr virus in pediatric multiple sclerosis. JAMA2004; 291(15): 1875—9.
8.
Banwell B., Krupp L., Kennedy J., Tellier R., Tenembaum S., Ness J. et al. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol2007; 6: 773—81.
9.
Ascherio A., Munch M.Epstein-Barr virus and multiple sclerosis. Epidemiology2000; 11(2): 220—4.
10.
Rickinson AB, Kieff E.Epstein-Barr virus. In Knipe DM, Howley PM eds. Fields virology. Philadelphia: Lippincott Williams & Wilkins, 2001: 2575—627.
11.
Wucherpfennig KW, Strominger JLMolecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein . Cell1995; 80(5): 695—705.
12.
Mikaeloff Y. , Suissa S., Vallee L., Lubetzki C., Ponsot G., Confavreux C. et al. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr2004; 144(2): 246—52.
13.
Simone IL, Carrara D., Tortorella C., Liguori M., Lepore V., Pellegrini F. et al. Course and prognosis in early-onset MS: comparison with adult-onset forms. Neurology2002; 59(12): 1922—8.
14.
Hafler DA, Compston A., Sawcer S., Lander ES, Daly MJ, De Jager PL et al. Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study. N Engl J Med2007; 357: 851—62.
15.
Dean G., Elian M.Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry1997; 63(5): 565—8.
16.
Kennedy J., O'Connor P., Sadovnick AD, Perara M., Yee I., Banwell B.Age at onset of multiple sclerosis may be influenced by place of residence during childhood rather than ancestry. Neuroepidemiology2006; 26(3): 162—7.